Cargando…

A mindfulness-based stress management program for caregivers of allogeneic hematopoietic stem cell transplant (HCT) patients: Protocol for a randomized controlled trial

OBJECTIVES: Caregivers of allogeneic hematopoietic stem cell transplant (HCT) cancer patients experience high caregiver burden and carry a significant amount of responsibility. Mindfulness has the potential to lessen caregiver burden by aiding in stress management. To date, no studies have examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Min-Jeong, Yepez, Valerie V., Brandon, Karen O., Reblin, Maija, Pidala, Joseph, Jim, Heather S. L., Meyer, Jerrold S., Gore, L. Robert, Khera, Nandita, Lau, Penny, Sauls, Rachel M., Jones, Sarah R., Vinci, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975158/ https://www.ncbi.nlm.nih.gov/pubmed/35363799 http://dx.doi.org/10.1371/journal.pone.0266316

Ejemplares similares

Correction: A mindfulness-based stress management program for caregivers of allogeneic hematopoietic stem cell transplant (HCT) patients: Protocol for a randomized controlled trial
por: Yang, Min-Jeong, et al.
Publicado: (2022)

Early Respiratory Viral Acquisition after Allogeneic Hematopoietic Cell Transplant (HCT)
por: Boonyaratanakornkit, Jim, et al.
Publicado: (2019)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
por: Jayani, Reena V., et al.
Publicado: (2021)

Biomarkers for Allogeneic HCT Outcomes
por: Adom, Djamilatou, et al.
Publicado: (2020)

1548. Risk of Severe Herpes Zoster (HZ) in Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients
por: Baumrin, Emily, et al.
Publicado: (2018)

1753. Adherence and Immunogenicity of Early Vaccination in Pediatric Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients
por: Danino, Dana, et al.
Publicado: (2019)

Maintenance therapy for AML after allogeneic HCT
por: Nayak, Rahul K., et al.
Publicado: (2022)

RESOURCE UTILIZATION AMONG FAMILY CAREGIVERS: INDIVIDUAL AND NEIGHBORHOOD CHARACTERISTICS
por: Choi, Hyojin, et al.
Publicado: (2022)

Managing Survivorship after Hematopoietic Cell Transplantation
por: Khera, Nandita
Publicado: (2023)

Tolerance Associated Gene Expression following Allogeneic Hematopoietic Cell Transplantation
por: Pidala, Joseph, et al.
Publicado: (2015)

Patient education in allogeneic hematopoietic cell transplant: What patients wish they had known about quality of life
por: Jim, Heather S.L., et al.
Publicado: (2013)

1077. Infectious complications after second allogeneic hematopoietic cell transplant (allo-HCT) in adult patients with hematological malignancies
por: Maurer, Stephen, et al.
Publicado: (2020)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

Hospice Family Caregivers’ Use of Audio Diaries
por: Cloyes, Kristin, et al.
Publicado: (2020)

1001. Feasibility and Outcomes of a Pre-Transplant Antibiotic Allergy Evaluation Program for Allogeneic Hematopoietic Cell Transplant (HCT) Candidates
por: Liu, Catherine, et al.
Publicado: (2019)

Pilot Study of Patient and Caregiver Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation
por: Majhail, Navneet S, et al.
Publicado: (2012)

Assessment of Serology after Sars-Cov-2 Vaccine in Allogeneic HCT Recipients
por: Baker, Melissa, et al.
Publicado: (2021)

Beyond Biology: Impact of Center- and Country-specific Economic Factors on Outcomes After Hematopoietic Cell Transplantation
por: Khera, Nandita
Publicado: (2015)

ALIGNMENT OF COMMUNICATION AND SUPPORT NEEDS BETWEEN LGBTQ+ FAMILY CAREGIVERS OF HOSPICE PATIENTS AND PROVIDERS
por: Cloyes, Kristin, et al.
Publicado: (2022)

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
por: Passweg, Jakob R., et al.
Publicado: (2019)

Mindfulness in Adolescent and Young Adult (AYA) Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Qualitative Study
por: Crowder, Sylvia L., et al.
Publicado: (2022)

1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT)
por: Kusztos, Amanda E, et al.
Publicado: (2018)

Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Dimitrova, Dimana, et al.
Publicado: (2022)

Abstract 6 Projected Impact of Omidubicel on Racial and Ethnic Disparities in Allogeneic Hematopoietic Cell Transplant Access and Outcomes for Patients with Hematologic Malignancies in the U.S.
por: Gergis, Usama, et al.
Publicado: (2022)

Daily received support and relational functioning in HCT survivors and their caregivers
por: Kroemeke, Aleksandra, et al.
Publicado: (2020)

Prognostic prediction of novel risk scores (AML-DRG and AML-HCT-CR) in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation
por: Cao, Weijie, et al.
Publicado: (2022)

Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
por: Jain, Tania, et al.
Publicado: (2020)

Hospice Caregivers’ Perception of Family and Non-Family Social Support and Stress over Time: Associations with Reports of General Support
por: Reblin, Maija, et al.
Publicado: (2023)

Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy
por: Gaballa, Ahmed, et al.
Publicado: (2022)

568. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
por: Khawaja, Fareed, et al.
Publicado: (2020)

Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
por: Foolad, Farnaz, et al.
Publicado: (2017)

Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
por: Perez, Lia Elena, et al.
Publicado: (2016)

Patient and Caregiver Symptom Trajectory: The Last 2 Months of Cancer Home Hospice
por: Reblin, Maija, et al.
Publicado: (2021)

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
por: Betts, Brian C., et al.
Publicado: (2017)

Cancer caregivers at the end-of-life: How much me vs. how much we?
por: Bybee, Sara, et al.
Publicado: (2023)

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
por: Pidala, Joseph, et al.
Publicado: (2010)

The Burden of Having to Wonder: Minority Stress Experiences of LGBTQ+ Hospice Family Caregivers
por: Cloyes, Kristin, et al.
Publicado: (2021)

281. Detecting bacterial sepsis among allogeneic HCT recipients with population-specific bedside tools
por: Lind, Margaret, et al.
Publicado: (2020)

P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WITHOUT CYTOPENIAS
por: Koehne, Guenther, et al.
Publicado: (2023)

A randomized control trial of a psychosocial intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: Effects on distress
por: Laudenslager, Mark L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_18ov782uc6kpb45dgckonfucri